Does ENZALUTAMIDE Cause Haemoglobin decreased? 317 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 317 reports of Haemoglobin decreased have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.6% of all adverse event reports for ENZALUTAMIDE.
317
Reports of Haemoglobin decreased with ENZALUTAMIDE
0.6%
of all ENZALUTAMIDE reports
66
Deaths
175
Hospitalizations
How Dangerous Is Haemoglobin decreased From ENZALUTAMIDE?
Of the 317 reports, 66 (20.8%) resulted in death, 175 (55.2%) required hospitalization, and 6 (1.9%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 317 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which ENZALUTAMIDE Alternatives Have Lower Haemoglobin decreased Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE